Prof. Yanqiang Wang, Department of Neurology Ⅱ, The Affiliated Hospital of Shandong Second Medical University, China
Yanqiang Wang, Ph.D., is a distinguished neurologist specializing in the pathogenesis and neuroprotection of ischemic brain injury and Parkinson’s disease. He is currently a director at the Affiliated Hospital of Shandong Second Medical University, where he has been serving since 2015. Dr. Wang earned his Master’s degree in Neurology from Xuzhou Medical University in 2006, focusing on the pathogenesis of Parkinson’s disease. He later obtained his Ph.D. in Neurology from Sun Yat-sen University in 2015, conducting clinical research on ischemic stroke and neuromyelitis optica spectrum disorders. He further pursued postdoctoral research at Xuzhou Medical University (2016–2019), continuing his work on ischemic stroke mechanisms. Throughout his career, he has held key medical and academic positions, including Vice Director of the Department of Neurology at the University of Washington (2020). His expertise spans cerebrovascular diseases, systemic autoimmune disorders, and neurodegenerative conditions, making significant contributions to both clinical practice and research.
Professional Profile:
ORCID
Suitability for the Best Researcher Award
Dr. Yanqiang Wang is a highly qualified researcher specializing in neurology, cerebrovascular diseases, ischemic stroke, Parkinson’s disease, and neuromyelitis optica spectrum disorders. His academic background, professional experience, and extensive research contributions make him a strong candidate for the Best Researcher Award.
🎓 Education
- Master’s Degree in Neurology (2003–2006) – Xuzhou Medical University
Research: Pathogenesis of Parkinson’s Disease
- Ph.D. in Neurology (2012–2015) – Sun Yat-sen University
Research: Pathogenesis and clinical study of ischemic stroke & neuromyelitis optica spectrum disorders
- Postdoctoral Research (2016–2019) – Xuzhou Medical University, Department of Neurology
Research: Pathogenesis and clinical study of ischemic stroke
💼 Work Experience
- Resident & Attending Doctor (2006–2012) – Affiliated Hospital of Weifang Medical University, Department of Immunology and Rheumatology
Research: Systemic lupus erythematosus and rheumatoid arthritis
- Attending Doctor, Vice Director & Director (2015–Present) – Affiliated Hospital of Shandong Second Medical University, School of Clinical Medicine
Research: Cerebrovascular disease, ischemic stroke, and neuromyelitis optica spectrum disorders
- Vice Director, Department of Neurology (2020) – University of Washington, USA
Research: Cerebrovascular disease
🏆 Achievements & Contributions
- Published multiple research papers in top neurology journals
- Leading investigator in ischemic stroke and Parkinson’s disease research
- Conducted clinical studies on neuromyelitis optica spectrum disorders
- Active in neurological research collaborations between China and the USA
🎖 Awards & Honors
- Outstanding Researcher Award – Sun Yat-sen University 🏅
- Excellence in Clinical Research – Xuzhou Medical University 🏥
- Recognition for Contribution in Neurology – University of Washington 🎖
- Best Paper Award at an international neurology conference 📜
Publication Top Notes:
Influence of the brain‑gut axis on neuroinflammation in cerebral ischemia‑reperfusion injury (Review)
Inhibition of the cGAS–STING pathway: contributing to the treatment of cerebral ischemia-reperfusion injury
Exploring the Neuroprotective Effects of Lithium in Ischemic Stroke: A literature review
Risk Factors and Clinical Characteristics of First-ever Ischemic Stroke Caused by ICAS with Leukoaraiosis
1,25-D3 ameliorates ischemic brain injury by alleviating endoplasmic reticulum stress and ferroptosis: Involvement of vitamin D receptor and p53 signaling